West Nile virus’ spread through nerve cells linked to serious complication
Scientists believe they have found an explanation for a puzzling and serious complication of West Nile virus infection. Researchers showed that the virus can enter a nerve cell, replicate and move on to infect other nearby nerve cells. Viruses traveling this infectious pathway can break into the central nervous system, triggering a condition known as acute flaccid paralysis that leaves one or more limbs limp and unresponsive.
October 2007 Radio Service
Listed below are this month’s featured news stories.
• Bright tumors, dim prospects (week of Oct. 3)
• New drugs for Parkinson’s (week of Oct. 10)
• Heart disease in the mentally ill (week of Oct. 17)
• Preventing plaque buildup (week of Oct. 24)
• Helping children lose weight (week of Oct. 31)
Obese children show early signs of heart disease
Children who are obese or who are at risk for obesity show early signs of heart disease similar to obese adults with heart disease, a study by researchers at the School of Medicine has found. “Based on this study, these subtle markers can help us predict who could be at risk for heart disease and heart attacks,” said Angela Sharkey, M.D., associate professor of pediatrics at the School of Medicine and a pediatric cardiologist at St. Louis Children’s Hospital.
Severely mentally ill at high risk for cardiovascular disease
A psychiatrist at the School of Medicine writes in the Journal of the American Medical Association (JAMA) that although mortality from cardiovascular disease has declined in the United States over the past several decades, patients with severe psychiatric illness are not enjoying the benefits of that progress.
Study suggests existing drugs may be useful in treating brain tumors
Scientists have shown how developing brain tumors can turn an encounter with a signaling molecule from a fatal experience for the tumor cells into a cue for their own growth and multiplication. Researchers at the School of Medicine found the transformation relies on at least two other molecules that can be modified with existing drugs, opening the possibility that they may be able to use the established drugs to treat brain tumors.
Shaw is named a Howard Hughes Medical Institute investigator
ShawAndrey Shaw, the Emil R. Unanue Professor of Immunobiology in the Department of Pathology and Immunology at the School of Medicine, has been named an investigator of the Howard Hughes Medical Institute (HHMI). Shaw was one of 15 researchers selected nationwide.
Susan Mackinnon elected to Institute of Medicine
MackinnonSusan Mackinnon has been elected to the Institute of Medicine of the National Academy of Sciences, one of the highest honors medical scientists in the United States can receive. Mackinnon was honored for her professional achievement in the health sciences.
Children need help to lose weight and keep it off, researchers find
Studying efforts to combat obesity in children, a research team led by investigators at the School of Medicine has found that children who lose weight are able to keep it off more effectively if they participate in a maintenance-targeted treatment program, although the effectiveness of the maintenance program lessens over time. The researchers report their findings in the Oct. 10 issue of the Journal of the American Medical Association.
Stenson named Costrini Professor
William F. Stenson, M.D., has been named the Dr. Nicholas V. Costrini Professor of Gastroenterology & Inflammatory Bowel Disease at the School of Medicine. Washington University Chancellor Mark S. Wrighton made the announcement with Larry J. Shapiro, M.D., executive vice chancellor for medical affairs and dean of the School of Medicine.
New $10 million MacArthur project integrates law and neuroscience
The John D. and Catherine T. MacArthur Foundation is bringing together a distinguished group of scientists, legal scholars, jurists and philosophers from across the country to help integrate new developments in neuroscience into the U.S. legal system. The Law and Neuroscience Project is the first systematic effort to bridge the fields of law and science in considering how courts should deal with new brain-scanning techniques as they apply to matters of law.
Older Stories